<DOC>
	<DOCNO>NCT02336737</DOCNO>
	<brief_summary>The purpose pivotal study provide prospective evidence SentiMag®/SiennaXP® safe non-inferior current standard care lymph node localization patient breast cancer part sentinel lymph node biopsy ( SLNB ) procedure summarize measure product safety performance .</brief_summary>
	<brief_title>SentiMag® Intraoperative Comparison Breast Cancer</brief_title>
	<detailed_description>This pivotal , prospective , open label , multicenter , pair comparison SentiMag® SiennaXP® magnetic sentinel node localization system standard care ( radioisotope blue dye ) lymph node localization detection lymph node patient breast cancer undergo sentinel lymph node biopsy . The trial design provide power evidence lymph node detection rate SentiMag® SiennaXP® system non-inferior standard care patient breast cancer .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Technetium Tc 99m Sulfur Colloid</mesh_term>
	<criteria>Subjects diagnosis primary breast cancer subject pure ductal carcinoma situ ( DCIS ) . Subjects schedule surgical intervention , sentinel lymph node biopsy procedure part surgical plan . Subjects age 18 year time consent . Subjects ECOG ( Eastern Cooperative Oncology Group ) performance status Grade 0 2 . Subject clinical negative node status ( i.e . T03 , N0 , M0 ) . The subject pregnant lactating . The subject clinical radiological evidence metastatic cancer include palpably abnormal enlarge lymph node . The subject know hypersensitivity Isosulfan Blue Dye . The subject participate another investigational drug study within 30 day schedule surgery . Subject either ) previous axilla surgery , b ) reduction mammoplasty , c ) lymphatic function impair surgeon 's judgment . Subject preoperative radiation therapy affect breast axilla . Subject receive Feraheme® ( ferumoxytol ) Injection within past 6 month . Subject intolerance hypersensitivity iron dextran compound SiennaXP . Subject iron overload disease . Subject pacemaker implantable device chest wall .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>breast cancer</keyword>
	<keyword>sentinel lymph node biopsy</keyword>
</DOC>